在血管炎患者中理解COVID-19疫苗的犹
Imama N Butt1, Charmaine van Eeden1, Katharina Kovacs Burns1
1Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Frontiers in public health
|December 19, 2023
概括
由于安全担忧和对医疗保健的不信任,疫苗犹性血管炎患者对COVID-19疫苗的担忧更高. 解决这些患者特异性问题的关键是明智的免疫决策.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 风湿病患者可能有独特的因素影响COVID-19疫苗决策.
- 了解这些因素对于公共卫生倡议至关重要.
研究的目的:
- 在血管炎患者中确定影响COVID-19疫苗决策的因素.
- 将这些因素与其他类风湿病患者的因素进行比较.
主要方法:
- 调查成年类风湿病患者的横截面研究 (2021年6月至8月).
- 用于数据收集的匿名在线问卷.
- 通过千平方测试进行统计分析.
主要成果:
- 10.6%的血管炎患者拒绝了COVID-19疫苗,而其他患者的比例为6.3%.
- 疫苗犹性血管炎患者对疫苗安全性和成分的担忧更大.
- 这些患者对医疗保健信息和提供者的信心较低.
结论:
- 血管炎患者对疫苗的犹与安全问题和对医疗保健的不信任有关.
- 以患者为中心的讨论对于知情的免疫选择至关重要.
- 解决系统和提供者相关的看法是很重要的.
相关概念视频
Endocarditis I: Introduction
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis III: Medical Management
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...


